Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

7 structures for Q8BND5

Entry ID Method Resolution Chain Position Source
3T58 X-ray 240 A A/B/C/D 36-550 PDB
3T59 X-ray 280 A A/B/C/D 36-550 PDB
5D8I X-ray 205 A A/B 36-275 PDB
5D93 X-ray 220 A A/D 36-275 PDB
5D96 X-ray 230 A A/D 36-275 PDB
6HF1 X-ray 194 A A/D 37-274 PDB
AF-Q8BND5-F1 Predicted AlphaFoldDB

50 variants for Q8BND5

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388506429 29 G>D No EVA
rs3390841897 46 T>A No EVA
rs13466752 67 E>K No EVA
rs3388506415 70 A>G No EVA
rs864275903 80 A>V No EVA
rs3388503487 115 E>D No EVA
rs3388505645 134 G>D No EVA
rs864281869 137 A>T No EVA
rs3388510487 170 P>S No EVA
rs33699385 180 D>N No EVA
rs265379697 181 G>E No EVA
rs3388506499 189 D>V No EVA
rs3388510483 227 D>E No EVA
rs33700225 230 N>S No EVA
rs3388507738 238 P>L No EVA
rs3388505296 271 G>E No EVA
rs3388503464 291 P>S No EVA
rs3388505640 328 Q>K No EVA
rs3388509063 334 K>* No EVA
rs3388507729 341 A>G No EVA
rs3388510491 346 G>W No EVA
rs3388503470 355 H>L No EVA
rs3388509141 358 N>Y No EVA
rs3390756602 436 Q>* No EVA
rs3390674203 436 Q>L No EVA
rs3390752248 438 V>D No EVA
rs265158195 457 D>N No EVA
rs3388509080 464 A>V No EVA
rs3388505699 482 T>N No EVA
rs3388507744 485 N>D No EVA
rs13466753 500 H>Y No EVA
rs3388507748 503 K>N No EVA
rs3388505516 510 E>D No EVA
rs3388509193 510 E>V No EVA
rs3388509018 530 A>G No EVA
rs3388505288 534 F>L No EVA
rs244249716 556 R>W No EVA
rs227192605 559 S>R No EVA
rs33703172 580 L>S No EVA
rs33703173 598 V>I No EVA
rs235379606 600 A>T No EVA
rs3388505697 623 G>R No EVA
rs245214105 629 R>H No EVA
rs33703884 632 D>E No EVA
rs3388509082 639 E>V No EVA
rs3388508258 641 A>G No EVA
rs31403791 656 F>L No EVA
rs3390826106 724 G>A No EVA
rs3388509126 742 H>Q No EVA
rs3388505722 745 Y>* No EVA

No associated diseases with Q8BND5

4 regional properties for Q8BND5

Type Name Position InterPro Accession
domain Thioredoxin domain 26 - 159 IPR013766
domain ERV/ALR sulfhydryl oxidase domain 399 - 507 IPR017905
domain Sulfhydryl oxidase, flavin adenine dinucleotide (FAD) binding domain 298 - 399 IPR040986
domain Sulfhydryl oxidase, Trx-like domain 165 - 272 IPR041269

Functions

Description
EC Number 1.8.3.2 With oxygen as acceptor
Subcellular Localization
  • [Isoform 1]: Golgi apparatus membrane ; Single-pass membrane protein
  • Secreted
  • A small proportion is secreted, probably via a proteolytic cleavage that removes the membrane anchor
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of Golgi membrane The component of the Golgi membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
intercellular bridge A direct connection between the cytoplasm of two cells that is formed following the completion of cleavage furrow ingression during cell division. They are usually present only briefly prior to completion of cytokinesis. However, in some cases, such as the bridges between germ cells during their development, they become stabilised.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.

3 GO annotations of molecular function

Name Definition
FAD binding Binding to the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
flavin-linked sulfhydryl oxidase activity Catalysis of the formation of disulfide bridges in proteins using FAD as the electron acceptor.
protein disulfide isomerase activity Catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins.

3 GO annotations of biological process

Name Definition
extracellular matrix assembly The aggregation, arrangement and bonding together of the extracellular matrix.
negative regulation of macroautophagy Any process that stops, prevents, or reduces the frequency, rate or extent of macroautophagy.
protein folding The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q6ZRP7 QSOX2 Sulfhydryl oxidase 2 Homo sapiens (Human) PR
10 20 30 40 50 60
MRRCGRLSGP PSLLLLLLLL SPLLFSGPGA YAARLSVLYS SSDPLTLLDA DSVRPTVLGS
70 80 90 100 110 120
SSAWAVEFFA SWCGHCIAFA PTWKELANDV KDWRPALNLA VLDCAEETNS AVCREFNIAG
130 140 150 160 170 180
FPTVRFFQAF TKNGSGATLP GAGANVQTLR MRLIDALESH RDTWPPACPP LEPAKLNDID
190 200 210 220 230 240
GFFTRNKADY LALVFEREDS YLGREVTLDL SQYHAVAVRR VLNTESDLVN KFGVTDFPSC
250 260 270 280 290 300
YLLLRNGSVS RVPVLVESRS FYTSYLRGLP GLTRDAPPTT ATPVTADKIA PTVWKFADRS
310 320 330 340 350 360
KIYMADLESA LHYILRVEVG KFSVLEGQRL VALKKFVAVL AKYFPGQPLV QNFLHSINDW
370 380 390 400 410 420
LQKQQKKRIP YSFFKAALDS RKEDAVLTEK VNWVGCQGSE PHFRGFPCSL WVLFHFLTVQ
430 440 450 460 470 480
ANRYSEAHPQ EPADGQEVLQ AMRSYVQFFF GCRDCADHFE QMAAASMHQV RSPSNAILWL
490 500 510 520 530 540
WTSHNRVNAR LSGALSEDPH FPKVQWPPRE LCSACHNELN GQVPLWDLGA TLNFLKAHFS
550 560 570 580 590 600
PANIVIDSSA SRHTGRRGSP EATPELVMDT LKLESRNSVL GHEQAASAES PGATALDVPA
610 620 630 640 650 660
EKPEASGPQE LYTGLRMGGA SPGQGPPERM EDHQRDMQEN APGQQHLSKR DTEALFLPEV
670 680 690 700 710 720
NHLQGPLELR RGGRSPKQLA PILEEEPEAL AIQGQGQWLQ VLGGGISHLD ISLCVGLYSV
730 740
SFMGLLAMYT YFRARLRTPK GHASYPTA